Recommendations from the Heart Rhythm Society Task Force on device performance policies and guidelines

被引：127

作者：

Carlson, Mark D. ^{[1
]}

Wilkoff, Bruce L.

Maisel, William H.

Ellenbogen, Kenneth A.

Saxon, Leslie A.

Prystowsky, Eric N.

Alpert, Joseph S.

Cain, Michael E.

Ching, Elizabeth A.

Curtis, Anne B.

Davies, D. Wyn

Hammill, Stephen C.

Hauser, Robert G.

Lampert, Rachel

Zipes, Douglas P.

机构：

[1] Univ Hosp Cleveland, Cleveland, OH 44106 USA

[2] Case Western Reserve Univ, Cleveland, OH 44106 USA

[3] Cleveland Clin Fdn, Cleveland, OH 44195 USA

[4] Beth Israel Deaconess Med, Boston, MA USA

[5] VCU Med Ctr, Richmond, VA USA

[6] USC Univ Hosp, Los Angeles, CA USA

[7] Care Grp LLC, Indianapolis, IN USA

[8] Univ Arizona, Tucson, AZ 85721 USA

[9] Washington Univ, Sch Med, St Louis, MO 63130 USA

[10] Univ S Florida, Tampa, FL 33620 USA

[11] St Marys Hosp, London, England

[12] Mayo Clin, Coll Med, Rochester, MN USA

[13] Minneapolis Heart Inst, Minneapolis, MN USA

[14] Yale Univ, Sch Med, New Haven, CT 06520 USA

[15] Krannert Cardiovasc Res Inst, Indianapolis, IN USA

来源：

HEART RHYTHM | 2006年 / 3卷 / 10期

关键词：

IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; ANTIARRHYTHMIC-DRUG THERAPY; SICK-SINUS SYNDROME; PACEMAKER IMPLANTATION; MYOCARDIAL-INFARCTION; CARDIAC-PACEMAKERS; RANDOMIZED-TRIAL; LEAD EXTRACTION; COMPLICATIONS; INFECTIONS;

D O I：

10.1016/j.hrthm.2006.08.029

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1250 / 1273

页数：24

共 57 条

[51] Cost-effectiveness of implantable cardioverter-defibrillators
Sanders, GD
Hlatky, MA
Owens, DK
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (14) : 1471 - 1480
[52] Infections with nonthoracotomy implantable cardioverter defibrillators: Can these be prevented?
Smith, PN
Vidaillet, HJ
Hayes, JJ
Wethington, PJ
Stahl, L
Hull, M
Broste, SK
[J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1998, 21 (01): : 42 - 55
[53] PERFORMANCE OF IMPLANTABLE CARDIAC-RHYTHM MANAGEMENT DEVICES
SONG, SL
BILITCH, M
FURMAN, S
GROSS, J
FRAME, R
JOHNSTON, D
PARSONNET, V
ROTHBART, ST
ZIMMERMAN, J
KAWANISHI, DT
PERRY, GY
HASHIMOTO, KK
BUCKINGHAM, TA
GOLDIN, MD
STALLER, BJ
DENKER, ST
LIPTON, IH
CASTLE, LW
SHEWCHIK, JM
HARTHORNE, JW
RUSKIN, JN
GARAN, H
MCGOVERN, BA
GRIFFIN, JC
SCHEINMAN, MM
LESH, MD
DORIAN, P
NEWMAN, D
DENES, P
DAHL, W
SAKSENA, S
KROL, RB
FOGOROS, RN
[J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1994, 17 (04): : 692 - 708
[54] *STUD GROUP 2 GLOB, MED DEV POST MARK SU
[55] High incidence of device-related and lead-related complications in the dual-chamber implantable cardioverter defibrillator compared with the single-chamber version
Takahashi, T
Bhandari, AK
Watanuki, M
Cannom, DS
Sakurada, H
Hiraoka, M
[J]. CIRCULATION JOURNAL, 2002, 66 (08) : 746 - 750
[56] *US DEP HHS FOOD D, 1999, MAN RISKS MED PROD U
[57] 2002, FED REG, V67, P38878

← 1 2 3 4 5 6 →